Scott L. Burrows

Insider Reports History

Entity
Individual
Location
C/O Arcutis Biotherapeutics, Inc., 3027 Townsgate Road, Suite 300, Westlake Village, CA
Signature
/s/ Heidy King-Jones, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott L. Burrows:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Spyre Therapeutics, Inc. Chief Financial Officer Common Stock 116K $3.28M $28.17 Sep 3, 2024 Direct
Arcutis Biotherapeutics, Inc. Chief Financial Officer Common Stock 59.1K $209K $3.54 Mar 6, 2023 Direct
Spyre Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 70K Feb 1, 2024 Direct
Arcutis Biotherapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 55.8K Mar 2, 2023 Direct

Insider Reports Filed by Scott L. Burrows

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SYRE Spyre Therapeutics, Inc. Sep 3, 2024 1 -$522K 4 Sep 5, 2024 Chief Financial Officer
SYRE Spyre Therapeutics, Inc. Feb 1, 2024 1 $0 4 Feb 2, 2024 Chief Financial Officer
SYRE Spyre Therapeutics, Inc. Dec 22, 2023 1 $0 4 Dec 22, 2023 Chief Financial Officer
AGLE Aeglea BioTherapeutics, Inc. Sep 1, 2023 1 $0 4 Sep 5, 2023 Chief Financial Officer
AGLE Aeglea BioTherapeutics, Inc. Sep 1, 2023 0 $0 3 Sep 5, 2023 Chief Financial Officer
ARQT Arcutis Biotherapeutics, Inc. Mar 6, 2023 1 -$4.44K 4 Mar 8, 2023 Chief Financial Officer
ARQT Arcutis Biotherapeutics, Inc. Mar 2, 2023 2 $0 4 Mar 6, 2023 Chief Financial Officer
ARQT Arcutis Biotherapeutics, Inc. Feb 28, 2023 3 -$29.4K 4 Mar 2, 2023 Chief Financial Officer
ARQT Arcutis Biotherapeutics, Inc. Sep 16, 2022 2 $8.4K 4 Sep 20, 2022 Chief Financial Officer
ARQT Arcutis Biotherapeutics, Inc. Mar 3, 2022 4 -$5.1K 4 Mar 7, 2022 Chief Financial Officer
ARQT Arcutis Biotherapeutics, Inc. Mar 1, 2022 1 -$7.46K 4 Mar 3, 2022 Chief Financial Officer
ARQT Arcutis Biotherapeutics, Inc. Dec 30, 2021 1 $0 4 Jan 4, 2022 Chief Financial Officer
ARQT Arcutis Biotherapeutics, Inc. Dec 27, 2021 1 -$252K 4 Dec 28, 2021 Chief Financial Officer